Fact-checked by Grok 2 weeks ago

Menstruation

Menstruation is the shedding of the functional layer of the uterine endometrium, accompanied by vaginal bleeding, that occurs cyclically in non-pregnant human females of reproductive age following the luteal phase of the ovarian cycle.^[1] This process marks the onset of the menstrual cycle, a coordinated sequence of hormonal events preparing the reproductive system for potential pregnancy.^[2] The average menstrual cycle length, based on large-scale tracking data, is approximately 29 days, though it typically ranges from 21 to 35 days, with individual variation influenced by factors such as age and health.^[3]^[4] The menstrual cycle is regulated by the interplay of gonadotropin-releasing hormone from the hypothalamus, follicle-stimulating hormone and luteinizing hormone from the anterior pituitary, and ovarian steroids including estrogen and progesterone.^[5] In the follicular phase, rising estrogen levels promote endometrial proliferation; ovulation follows a luteinizing hormone surge, after which the corpus luteum secretes progesterone to maintain the endometrium.^[2] Absent implantation, declining progesterone triggers endometrial breakdown and menstruation, lasting 3 to 7 days with blood loss averaging 30-40 milliliters.^[5] This cycle serves as a vital sign of endocrine and reproductive health, with irregularities often indicating underlying conditions like polycystic ovary syndrome or thyroid dysfunction.^[6] Evolutionarily, menstruation may represent a costly but adaptive mechanism, potentially evolved to protect against uterine pathogens introduced via insemination or as a byproduct of thick endometrial preparation for implantation in species with invasive placentation.^[7] Empirical studies highlight its rarity among mammals, occurring visibly in humans and a few primates, underscoring its link to hemochorial placentation and high energetic investment in reproduction.^[8] While culturally stigmatized in some societies, menstruation fundamentally signals fertility and ovulatory function, with suppression via hormonal contraceptives representing a modern intervention altering natural cyclicity.^[1]

Biological Definition and Physiology

Definition and Species Occurrence

Menstruation is the periodic shedding of the endometrium, the inner lining of the uterus, resulting in vaginal discharge of blood, mucus, and tissue fragments, which occurs in reproductively mature females of certain mammalian species in the absence of pregnancy.^[2] This process is triggered by a decline in progesterone levels following the regression of the corpus luteum, leading to localized endometrial breakdown and expulsion.^[9] In humans, menstruation typically begins at menarche, around age 12 on average, and continues monthly until menopause, approximately age 51, unless interrupted by pregnancy, lactation, or other factors.^[4] Menstruation is rare among mammals, documented in fewer than 2% of species, or roughly 85 known cases, predominantly among primates.^[10] It occurs in haplorhine primates, including humans (Homo sapiens), great apes such as chimpanzees (Pan troglodytes), gorillas (Gorilla gorilla), and orangutans (Pongo spp.), as well as Old World monkeys like baboons (Papio spp.) and macaques (Macaca spp.); some New World monkeys in genera such as Cebus and Ateles also exhibit it.^[11] Outside primates, menstruation has been observed in elephant shrews (order Macroscelidea), the Cairo spiny mouse (Acomys cahirinus), and 3 to 5 bat species, including certain emballonurids and phyllostomids.^[12] These instances represent evolutionary convergences, with no menstruation reported in other mammalian orders like rodents (beyond the spiny mouse), carnivores, or artiodactyls, which instead rely on estrous cycles with concealed endometrial resorption.^[13] The scarcity underscores menstruation's specialization, potentially linked to thick endometrial development for implantation in species with high miscarriage risks or invasive placentation.^[14]

Menstrual Cycle Phases

The menstrual cycle typically lasts 28 days, though it ranges from 21 to 35 days in reproductive-age females, and is regulated by interactions between the hypothalamus, pituitary gland, and ovaries.^[2] It encompasses ovarian and endometrial changes divided into the menstrual phase, follicular phase, ovulation, and luteal phase.^[5] The menstrual phase begins on day 1 with the onset of bleeding and lasts 3 to 7 days on average.^[4] It involves the shedding of the functional layer of the endometrium due to declining levels of progesterone and estrogen following corpus luteum regression in the absence of pregnancy.^[2] Blood loss during this phase averages 20 to 90 ml.^[15] The follicular phase overlaps with the menstrual phase and extends from day 1 until ovulation, typically lasting 10 to 16 days with variability primarily affecting cycle length.^[5] Follicle-stimulating hormone (FSH) from the anterior pituitary stimulates the growth of ovarian follicles, one of which becomes dominant; rising estrogen from the follicles promotes endometrial proliferation and feedback inhibits FSH while eventually triggering a luteinizing hormone (LH) surge.^[2] Ovulation occurs approximately midway through the cycle, around day 14 in a 28-day cycle, triggered by a mid-cycle surge in LH that causes rupture of the mature follicle and release of the oocyte into the fallopian tube.^[5] This event lasts about 24 hours for oocyte viability but defines the fertile window spanning 5 days before to 1 day after.^[16] The luteal phase follows ovulation and lasts 12 to 14 days, relatively fixed in duration across cycles.^[5] The ruptured follicle transforms into the corpus luteum, which secretes progesterone to maintain the endometrial lining for potential implantation and inhibits further ovulation via negative feedback on gonadotropins; if no implantation occurs, the corpus luteum involutes, hormone levels drop, and menstruation ensues.^[2]

Hormonal and Physiological Mechanisms

The hormonal and physiological mechanisms of menstruation are orchestrated by the hypothalamic-pituitary-ovarian (HPO) axis, which regulates the menstrual cycle through pulsatile gonadotropin-releasing hormone (GnRH) secretion from the hypothalamus. GnRH stimulates the anterior pituitary gland to release follicle-stimulating hormone (FSH) and luteinizing hormone (LH), which in turn act on the ovaries to drive follicular development, ovulation, and corpus luteum formation.^[2]^[5] In the follicular phase, FSH promotes the growth of ovarian follicles, leading to rising estradiol (estrogen) levels that exert negative feedback on FSH secretion while stimulating endometrial proliferation. A mid-cycle surge in LH, triggered by positive feedback from peak estradiol, induces ovulation approximately 36 hours later. Post-ovulation, the ruptured follicle forms the corpus luteum, which secretes progesterone to maintain the secretory transformation of the endometrium and inhibit further gonadotropin release via negative feedback.^[2]^[5] Menstruation ensues in the absence of pregnancy when the corpus luteum regresses around day 24-26 of a typical 28-day cycle, causing abrupt declines in progesterone and estradiol concentrations. This hormonal withdrawal destabilizes the endometrium: progesterone cessation removes suppression of inflammatory mediators, leading to elevated prostaglandin F2α production, which induces arteriolar vasoconstriction, endometrial ischemia, and focal hemorrhage.^[2]^[17] Physiologically, the shedding involves enzymatic degradation of the extracellular matrix by matrix metalloproteinases (MMPs), particularly MMP-1, -3, and -9, activated in stromal cells and leukocytes infiltrating the decidua. Hypoxia from ischemia further upregulates MMP expression and proinflammatory cytokines like interleukin-8, fragmenting the functionalis layer while sparing the basalis for regeneration. This process typically lasts 3-7 days, with menstrual fluid comprising blood, endometrial cells, and mucin-stabilized thrombi, expelled via uterine contractions mediated by prostaglandins.^[17]^[18]^[19]

Characteristics of the Menstrual Event

Duration, Frequency, and Fluid Properties

The duration of menstrual bleeding in healthy women typically ranges from 2 to 7 days, with a median of 5 days and heavier flow often concentrated in the first 3 days.^[2] ^[20] Bleeding lasting 8 days or less falls within normal physiological variation, though durations shorter than 4 days or exceeding 7 days occur in fewer than 5% of cycles among regularly menstruating women.^[21] Individual factors such as age, hormonal status, and underlying conditions influence this range; for instance, cycles in adolescents may initially feature shorter or irregular durations that stabilize by the third year post-menarche.^[6] Menstruation recurs with a cycle length of 21 to 35 days in most ovulatory women, measured from the first day of one bleeding episode to the first day of the next.^[4] ^[22] This frequency aligns with the hormonal orchestration of the ovarian and endometrial cycles, where ovulation typically occurs mid-cycle, prompting endometrial shedding if no implantation follows. Cycle lengths outside 24 to 38 days may indicate anovulation or other disruptions, though variation of 4 to 11 days within individuals is common, particularly influenced by age and environmental factors.^[23]^[24] Menstrual fluid is a composite biological material comprising approximately 36% to 50% blood (primarily arterial with some venous components), alongside endometrial tissue fragments, cervical mucus, vaginal secretions, cellular debris, and prostaglandins.^[25] The average total fluid volume per cycle is 5 to 80 mL, with blood loss specifically averaging 30 to 40 mL—equivalent to 2 to 3 tablespoons—and rarely exceeding 80 mL without qualifying as abnormal. ^[28] This fluid exhibits variable properties, including a pH of around 7.4, potential for clotting due to fibrin, and colors ranging from bright red (fresh blood) to brown (oxidized remnants), reflecting the dynamic shedding and expulsion process.^[29]

Normal Symptoms and Individual Variations

Common symptoms during menstruation include lower abdominal cramping, known as dysmenorrhea, which affects 50% to 90% of women of reproductive age and is often accompanied by back pain, headache, nausea, and fatigue.^[30] Dysmenorrhea typically begins within hours of menstrual onset, peaks in intensity within 24 hours, and lasts 48 to 72 hours, resulting from uterine contractions driven by prostaglandins.^[31] Additional physical symptoms may involve bloating due to fluid retention and gastrointestinal changes such as diarrhea or constipation, reported in up to 73% of cycles.^[32] Premenstrual symptoms, occurring in the luteal phase prior to bleeding, encompass a range of somatic and psychological effects classified under premenstrual syndrome (PMS), experienced by 75% to 80% of menstruating women to some degree.^[33] These include breast tenderness, food cravings, irritability, anxiety, depressed mood, and sleep disturbances, with mood-related symptoms like irritability and mood swings prevalent in 70% to 80% of affected individuals.^[34] Fatigue and poor concentration are also frequent, impacting daily functioning in moderate to severe cases for 5% to 12% of women.^[35] Individual variations in symptom experience are substantial, with some women reporting minimal or no discomfort while others encounter debilitating pain or mood alterations; cycle-to-cycle fluctuations account for 79% to 98% of mood symptom variance, often deviating from predictable premenstrual exacerbation patterns.^[36] Factors influencing variability include age, with symptoms peaking in the 20s to 30s and potentially attenuating post-parity or with hormonal contraceptives; higher body mass index correlates with increased dysmenorrhea severity, while regular physical activity may mitigate it.^[37] Genetic predispositions, stress levels, and lifestyle elements such as smoking or caffeine intake further modulate symptom intensity and prevalence, underscoring the spectrum of physiological responses across populations.^[38]

Evolutionary and Comparative Biology

Theories on the Evolution of Menstruation

Several hypotheses have been proposed to explain the evolution of overt menstruation in humans and a few other primates, a trait absent in the vast majority of mammals, which instead reabsorb endometrial tissue without shedding.^[11] These theories generally posit adaptive benefits outweighing the energetic costs, estimated at approximately 10% of a woman's caloric intake per cycle due to tissue buildup and expulsion, including significant iron loss. Menstruation likely evolved independently multiple times, occurring in less than 2% of mammalian species, suggesting convergent selection pressures related to reproductive physiology.^[11] One prominent theory, advanced by anthropologist Beverly Strassmann, argues that menstruation functions as a defense mechanism against pathogens transmitted via semen, dislodging infected endometrial tissue to protect the uterus and oviducts from ascending infections.^[39] This hypothesis draws on comparative data showing higher pathogen loads in promiscuous mating systems and empirical observations from Strassmann's longitudinal studies of the Dogon people in Mali, where menstrual blood loss correlates with environmental pathogen pressures rather than mere waste disposal.^[40] Strassmann further contends that the energy expenditure of shedding, rather than reabsorbing, tissue is adaptive in species with concealed ovulation and frequent cycling, as it prevents chronic infections that could impair fertility more severely than periodic blood loss. Critics note that this model assumes high historical STD prevalence, though supporting evidence includes elevated uterine infection risks in non-menstruating mammals post-mating.^[39] An alternative framework, proposed by evolutionary geneticist Deena Emera and colleagues, views menstruation as a byproduct of genetically assimilated spontaneous decidualization—the preemptive thickening of the endometrium without embryonic signaling—allowing proactive preparation for highly invasive human implantation.^[11] In this model, failed pregnancies trigger inflammatory shedding to avoid retaining defective or non-viable embryos, which could otherwise lead to pathological retention or neoplasia; this stabilization occurred after decidualization shifted from embryo-induced (in most mammals) to spontaneous in anthropoid primates.^[41] Genomic analyses support this, revealing conserved molecular pathways for inflammation and tissue rejection in menstruating lineages, with menstruation enabling rejection of suboptimal implantations to enhance offspring quality amid energetically costly human gestation.^[11] Empirical backing includes observations that human embryos invasively remodel uterine arteries, necessitating robust clearance mechanisms absent in species with superficial implantation.^[42] A related implantation-focused hypothesis posits menstruation evolved to mitigate risks from the aggressive trophoblast invasion unique to humans, where partial or faulty embedding damages the endometrium, prompting shedding to prevent complications like retained products or chronic inflammation. This aligns with comparative physiology: non-menstruating mammals exhibit minimal endometrial turnover, while human cycles accommodate uncertain fertilization timing in concealed ovulation species.^[43] However, direct tests remain limited, with some models critiqued for overemphasizing costs without quantifying pathogen or implantation failure rates in ancestral environments.^[44] Overall, these theories converge on menstruation as an adaptation for high-fidelity reproduction, trading periodic losses for reduced long-term reproductive morbidity.^[11]^[39]

Menstruation Versus Estrous Cycles in Mammals

Menstruation occurs in a small minority of mammalian species, primarily certain primates, while the vast majority exhibit estrous cycles without overt endometrial shedding. In estrous cycles, characteristic of most mammals such as rodents, carnivores, and ungulates, the uterine endometrium proliferates during the luteal phase under progesterone influence but is largely reabsorbed or minimally degraded if implantation does not occur, avoiding significant blood loss.^[14]^[12] This process contrasts with menstruation, where the endometrium undergoes extensive necrosis and shedding, resulting in visible bleeding through the vagina.^[13] Estrous cycles typically feature discrete phases—proestrus, estrus (heat, marked by behavioral receptivity and ovulation), metestrus, and diestrus—with females sexually receptive only during estrus, often accompanied by overt signaling like vulvar swelling or pheromones.^[45]^[46] The menstrual cycle, observed in humans, other haplorhine primates (e.g., Old World monkeys and apes), some bats (e.g., four species including Pallas's long-tongued bat), the elephant shrew, and the spiny mouse (Acomys cahirinus), involves endometrial desquamation at cycle end if pregnancy fails, with blood loss averaging 30-80 mL in humans.^[10]^[13] Approximately 85 mammalian species, or less than 2% of known placental mammals, exhibit menstruation, with over 98% relying on estrous mechanisms.^[10]^[12] Unlike estrous cycles, menstrual cycles often lack strict behavioral estrus; in humans, ovulation is concealed, and sexual receptivity persists across phases, decoupling mating from peak fertility signals.^[47] Cycle lengths vary more in menstruating species—the human cycle averages 28 days but ranges 21-35 days—compared to the relatively fixed estrous intervals in non-menstruating mammals, such as 21 days in cows or 4-5 days in mice.^[45]^[48] Physiological differences extend to endometrial histology and hormone dynamics. Estrous endometria show spiral artery development but regress via apoptosis and phagocytosis without widespread hemorrhage, conserving energy and minimizing infection risk from blood exposure.^[14] Menstruating species, however, evolve thicker endometria with more extensive vascularization, leading to focal ischemia, necrosis, and expulsion upon progesterone withdrawal, potentially as an adaptive response to pathogen clearance or implantation failure detection.^[13]^[12] Luteal phases are generally shorter and less variable in estrous cycles, while follicular phases dominate variability in menstrual cycles, influencing overall cycle predictability.^[48] These distinctions highlight menstruation's rarity, likely tied to evolutionary trade-offs in reproductive strategy among mammals.^[14]

Health Implications and Disorders

Short-Term Physiological Effects

Menstruation commences with the withdrawal of progesterone and estrogen support in the absence of pregnancy, prompting vasoconstriction of endometrial spiral arterioles, ischemia, and enzymatic degradation of the functional endometrial layer. This leads to the shedding and expulsion of approximately 10-15 mm of tissue depth, primarily from the luminal two-thirds of the endometrium, mixed with blood and mucus to form menstrual effluent. The process involves localized inflammation, matrix metalloproteinase activation, and leukocyte infiltration, resembling a controlled wound breakdown followed by rapid re-epithelialization without scarring.^[2]^[17]^[19] Uterine smooth muscle contractions intensify during this phase due to elevated endometrial synthesis of prostaglandins, particularly PGF2α, which peaks at menses onset and promotes myometrial hyperactivity, arteriolar constriction, and pain via sensitization of nociceptors. These contractions, averaging 3-5 per 10 minutes and strongest on days 1-2, expel debris but can cause dysmenorrhea in up to 90% of women, characterized by lower abdominal cramping radiating to the back or thighs; severity correlates with prostaglandin levels, with higher concentrations linked to ischemia-induced pain. Systemically, prostaglandins may induce gastrointestinal effects like diarrhea or nausea by stimulating intestinal smooth muscle.^[49]^[50]^[51] Blood loss during a typical cycle ranges from 30 to 50 mL, comprising about 36% of total effluent volume, with heavier flows (up to 80 mL) still physiologically normal but potentially causing transient fatigue, pallor, or orthostatic symptoms from acute volume depletion in susceptible individuals. Iron loss averages 15-20 mg per cycle, insufficient for immediate anemia in most but contributing to cumulative depletion if uncompensated; empirical data show no significant short-term alterations in heart rate, oxygen uptake, or core temperature solely from normal menses. Hormonal nadirs sustain low energy or mild mood dips in some, though large-scale analyses find no consistent cognitive or performance impairments attributable to this phase.^[52]^[53]

Common Menstrual Disorders

Dysmenorrhea, the medical term for painful menstrual cramps, is one of the most prevalent menstrual complaints, affecting women through prostaglandin-induced uterine contractions that cause ischemia and pain. Primary dysmenorrhea, lacking underlying pelvic pathology, typically emerges shortly after menarche and resolves with nonsteroidal anti-inflammatory drugs targeting prostaglandin synthesis. Its global prevalence ranges from 16% to 91% among reproductive-age women, with severe forms impacting 2% to 29% and often leading to absenteeism or reduced productivity.^[54] ^[55] Secondary dysmenorrhea arises from conditions such as endometriosis or fibroids, with prevalence influenced by age and comorbidities; for instance, up to two-thirds of adolescents with chronic pelvic pain may have endometriosis-related secondary dysmenorrhea.^[56] Heavy menstrual bleeding (menorrhagia), defined as menstrual blood loss exceeding 80 mL per cycle or lasting longer than seven days, disrupts daily activities and risks iron-deficiency anemia due to excessive endometrial shedding or impaired hemostasis. Structural causes include uterine fibroids (leiomyomas), polyps, and adenomyosis, while dysfunctional uterine bleeding from anovulatory cycles or hormonal imbalances accounts for roughly 80% of cases without identifiable lesions. Coagulation disorders like von Willebrand disease contribute in 10-20% of adolescents with severe bleeding. Prevalence varies by population but affects an estimated 10-30% of reproductive-age women globally, with higher rates in regions with limited diagnostic access.^[57] ^[58] ^[59] Amenorrhea, the absence of menstruation, is classified as primary (no menarche by age 15-16 despite secondary sexual development) or secondary (cessation for three months in previously menstruating women, or six months if cycles were irregular). Primary amenorrhea has an incidence below 1% in the United States, often stemming from chromosomal anomalies like Turner syndrome or Müllerian agenesis. Secondary amenorrhea, more common, affects 3-5% of reproductive-age women and frequently results from hypothalamic suppression (e.g., due to excessive exercise or low body weight), polycystic ovary syndrome (prevalence 6-10%), or hyperprolactinemia. Pregnancy remains the leading cause, excluding transient cases from stress or medications.^[60] ^[61] ^[62] Premenstrual syndrome (PMS) encompasses physical and psychological symptoms like bloating, irritability, and fatigue occurring cyclically in the luteal phase, resolving post-menses; severe variants qualify as premenstrual dysphoric disorder (PMDD) with marked mood disturbances meeting DSM criteria. PMS symptoms affect up to 12% of women severely enough to impair function, linked to serotonin fluctuations and ovarian hormone sensitivity rather than absolute levels. PMDD prevalence is 3-8% among menstruating individuals, with confirmed diagnoses around 1.6-3.2% in rigorous studies, disproportionately impacting those with trauma histories or axis I psychiatric disorders.^[35] ^[63] ^[64] Endometriosis, involving ectopic endometrial tissue growth causing inflammation and scarring, manifests as secondary dysmenorrhea, chronic pelvic pain, or infertility in 30-50% of cases, with menstrual exacerbation due to retrograde menstruation and immune dysregulation. It affects approximately 10% (190 million) of reproductive-age women worldwide, though underdiagnosis persists due to invasive laparoscopy requirements for confirmation.^[65] ^[66]

Interactions with Other Health Conditions

Heavy menstrual bleeding can lead to iron deficiency anemia, as blood loss depletes iron stores, resulting in symptoms such as fatigue, headaches, and reduced oxygen-carrying capacity in red blood cells; this is the most common cause of iron deficiency in reproductive-aged women, affecting up to 40% of adolescents with heavy flows.^[67]^[58] Hypothyroidism often manifests with menorrhagia or oligomenorrhea due to disrupted hormonal regulation of endometrial shedding, while hyperthyroidism is associated with hypomenorrhea; these patterns arise from thyroid hormones' influence on gonadotropin release and ovarian function, with over half of hypothyroid women experiencing irregularities.^[68]^[69]^[70] In women with epilepsy, catamenial patterns occur where seizures increase during perimenstrual phases (days -3 to +3), the ovulatory period, or luteal phase, impacting approximately 40% of cases due to estrogen's proconvulsant effects contrasting progesterone's anticonvulsant properties; this hormonal interplay heightens seizure susceptibility when estrogen peaks or progesterone withdraws.^[71]^[72] Catamenial migraines, triggered by the premenstrual estrogen drop, affect women with migraine history, occurring from two days before to three days after menses onset in at least two of three cycles, often more severe and less responsive to standard treatments than non-menstrual attacks.^[73]^[74] Irregular or prolonged menstrual cycles correlate with elevated cardiovascular disease risk, including a 19-20% higher incidence of heart disease and atrial fibrillation, linked to underlying insulin resistance, dyslipidemia, and hypertension rather than menstruation per se; heavy bleeding further compounds this via chronic iron loss and inflammation.^[75]^[76]^[77] In diabetes, long cycles predict type 2 onset, particularly in obese women, while type 1 patients face glycemic variability—insulin sensitivity decreases in the luteal phase, causing blood sugar spikes treatable with adjusted dosing.^[78]^[79]^[80] Autoimmune conditions like systemic lupus erythematosus or Hashimoto's thyroiditis exhibit perimenstrual flares, driven by progesterone withdrawal and immune activation in the luteal-to-menstrual transition, intensifying joint pain, fatigue, and rashes; cycle irregularities also signal heightened disease activity via altered regulatory T-cell function.^[81]^[82]^[83] Premenstrual dysphoric disorder (PMDD), a severe PMS variant, overlaps with major depression and anxiety, with affected women showing 2-6 times higher lifetime mood disorder risk, attributable to serotonin dysregulation amplified by luteal-phase neurosteroid changes rather than primary psychiatric etiology.^[84]^[85]

Management and Medical Interventions

Hygiene Practices and Products

Menstrual hygiene practices center on using absorbent or collection products to manage vaginal blood flow while minimizing infection risk, odor, and leakage through regular changing and hand hygiene. The U.S. Centers for Disease Control and Prevention (CDC) recommends washing hands before and after handling products and changing them frequently based on flow to prevent bacterial growth.^[86] Common products include disposable pads, tampons, menstrual cups, and reusable options like cloth pads or underwear. Disposable sanitary pads, worn externally in underwear, consist of an absorbent core of cellulose or superabsorbent polymers topped with a permeable layer and backed by plastic to prevent leaks. They typically require changing every 4 to 8 hours, or more often during heavy flow, to avoid skin irritation or infection from prolonged moisture exposure.^[87] Tampons, inserted into the vagina, are made from compressed cotton, rayon, or blends and expand to absorb blood internally, with capacities varying by size from 5 to 30 milliliters. To mitigate risks like menstrual toxic shock syndrome (TSS)—linked to Staphylococcus aureus toxin production—tampons should be changed every 4 to 6 hours, avoided overnight continuously, and alternated with pads; post-1980 FDA regulations on absorbency reduced U.S. TSS cases from over 800 annually to fewer than 50 by the 1990s.^[88] ^[89] Menstrual cups, reusable devices of medical-grade silicone or rubber inserted to form a seal and collect blood, hold 20 to 30 milliliters and can be emptied every 4 to 12 hours depending on flow. Systematic reviews confirm their safety and efficacy, with no reported TSS cases in large studies and leakage rates comparable to or lower than tampons when fitted properly, though users with intrauterine devices face a potential expulsion risk requiring counseling.30111-2/fulltext) ^[90] Reusable cloth pads or menstrual underwear, made from layered fabrics like cotton or bamboo, absorb externally and must be changed every 4 to 6 hours, then washed with soap to remove blood and bacteria; life-cycle assessments show they generate 80 to 90 percent less waste and carbon emissions than disposables over multiple years, though improper cleaning can harbor pathogens.^[91] ^[92] Proper disposal involves wrapping used disposables in paper before binning to contain odor and prevent scavenging, while reusables demand immediate rinsing and machine washing to maintain hygiene; globally, inadequate practices contribute to environmental pollution, with disposable pads comprising up to 90 percent plastic that persists in landfills for centuries.^[93] Evidence from cohort studies emphasizes that consistent hygiene reduces vulvovaginal infections, underscoring the causal link between prolonged product wear and microbial overgrowth irrespective of product type.^[94]

Methods of Menstrual Suppression

Menstrual suppression refers to the intentional reduction or elimination of menstrual bleeding through hormonal interventions that stabilize the endometrial lining or inhibit cyclic hormonal fluctuations. These methods primarily involve progestin-dominant or combined estrogen-progestin contraceptives, which prevent ovulation and minimize endometrial buildup. Continuous or extended regimens, rather than cyclic use with placebo intervals, are employed to avoid withdrawal bleeding.^[95]^[96] Combined estrogen-progestin contraceptives, such as oral pills, transdermal patches, or vaginal rings, achieve suppression via extended cycles where active hormone phases are prolonged without hormone-free intervals. For oral contraceptives, users skip placebo pills and proceed directly to a new pack, resulting in breakthrough bleeding that typically diminishes over time; amenorrhea rates increase with prolonged use. This approach has been utilized since the development of combination pills in the 1960s, with clinical evidence supporting its safety for indefinite continuation in eligible individuals.^[97]^[98]^[96] Progestin-only methods offer alternatives for those contraindicating estrogen, often yielding higher amenorrhea rates due to direct endometrial thinning. Depot medroxyprogesterone acetate (DMPA, Depo-Provera), administered as intramuscular or subcutaneous injections every 12-13 weeks, induces amenorrhea in 55% of users by month 12 and 68% by month 24. Levonorgestrel-releasing intrauterine devices (LNG-IUDs, e.g., Mirena at 52 mg), inserted for up to 5-8 years, reduce bleeding progressively, with approximately 20% of users experiencing amenorrhea after three or more months. Subdermal implants like etonogestrel (Nexplanon), lasting up to 3 years, and progestin-only pills also contribute to suppression, though with variable initial spotting that improves to 80-90% amenorrhea or reduced bleeding by months 10-12 in many cases.^[99]^[100]^[101] These methods are selected based on patient preferences, contraindications, and desired duration, with progestin-only options preferred for breastfeeding individuals or those with estrogen-related risks. Efficacy in suppression correlates with adherence and method-specific pharmacokinetics, such as steady progestin release preventing cyclic changes.^[95]^[102]

Risks and Evidence on Suppression Outcomes

Menstrual suppression via continuous or extended regimens of combined hormonal contraceptives (CHC) or progestin-only methods, such as depot medroxyprogesterone acetate (DMPA), levonorgestrel-releasing intrauterine devices (LNG-IUD), or implants, achieves amenorrhea by inducing endometrial atrophy and inhibiting ovulation, with amenorrhea rates often increasing over time to 50-80% depending on the method.^[102] ^[96] These approaches are deemed safe and effective for short- to medium-term use in reproductive-aged individuals without contraindications, with studies showing no significant impact on future fertility, as evidenced by an 83% pregnancy rate within 12 months post-discontinuation, comparable to non-users.^[95] ^[102] Bone mineral density (BMD) concerns arise particularly with progestin-only methods like DMPA, which can cause significant BMD loss in the first year of use, especially in adolescents and young adults during peak bone accrual, with reductions up to 5-7% at the hip and spine; this loss is partially reversible after discontinuation but warrants monitoring and calcium/vitamin D supplementation.^[103] ^[104] Continuous CHC regimens show minimal or no adverse BMD effects, as estrogen components help preserve density.^[95] Long-term progestin-only suppression is generally avoided in those under 18 or with risk factors for osteoporosis due to these findings.^[95] Cardiovascular risks vary by method: CHC continuous use carries a small elevated risk of venous thromboembolism (VTE), similar to cyclic use (3-9 cases per 10,000 woman-years), influenced more by estrogen dose than suppression pattern, while progestin-only options like LNG-IUD or implants show no increased VTE, stroke, or myocardial infarction risk compared to non-users.^[105] ^[106] Progestin-only pills and injections do not elevate blood pressure or overall cardiovascular disease incidence, making them preferable for those with hypertension or cardiac conditions.^[107] ^[108] Common adverse outcomes include initial breakthrough or unscheduled bleeding, affecting up to 50% early in use but resolving in most by 6-12 months, alongside reports of headaches, abdominal pain, and mood changes, though these do not exceed cyclic regimen rates and contribute to discontinuation in 10-20% of users.^[102] ^[109] Evidence indicates potential protective effects against endometrial and ovarian cancers from prolonged suppression due to reduced ovulatory cycles and thinner endometrium, with risk reductions of 20-50% observed in long-term users, though data on decades-long suppression remain limited.^[110] Overall, while suppression alleviates dysmenorrhea and anemia in select cases, empirical outcomes emphasize individualized assessment, as long-term safety beyond 5-10 years lacks large-scale prospective trials.^[95] ^[96]

Societal and Cultural Contexts

Historical and Cross-Cultural Practices

In ancient Egypt, menstruation was associated with both ritual impurity and divine connotations linked to the goddess Isis, with men excused from tomb construction if exposed to menstruating women due to beliefs that contact could contaminate sacred spaces.^[111] Women likely managed flow using softened papyrus, lint, or other absorbent plant materials wrapped in linen, as evidenced by medical papyri and archaeological inferences, though direct artifacts are scarce.^[112] In ancient Greece and Rome, humoral theory framed menstruation as a purging of excess blood to balance bodily fluids, with durations ideally three days; deviations were treated medically via fumigations or potions.^[113] Roman sources like Pliny the Elder attributed potent properties to menstrual blood, claiming it could cure erysipelas when applied topically or blight crops if spilled, reflecting dual views of it as medicinal yet hazardous.^[114] Hygiene involved wool tampons or linen rags secured by belts, but taboos restricted sexual activity and household duties during bleeding.^[115] Medieval European practices relied on reusable rags, moss, or peat stuffed into undergarments, often laundered infrequently due to limited water access and bathing norms, leading to rudimentary hygiene without standardized products until the 19th century.^[116] Church-influenced doctrines, drawing from Leviticus, deemed menstruating women ritually unclean, prohibiting communion or marital relations, though empirical evidence of health risks from poor sanitation was overlooked in favor of symbolic purity concerns.^[117] Cross-culturally, seclusion practices persisted in South Asian Hindu and indigenous Nepali traditions, where women were isolated in menstrual huts (chhaupadi) to avoid polluting food, temples, or men, rooted in Vedic texts viewing blood as impure and dating to at least 1500 BCE.^[118] In these systems, menstruants faced dietary bans on sour foods and restrictions from cooking or farming, with huts providing minimal shelter but exposing women to environmental hazards.^[119] Among some Native American tribes in the southeastern U.S., 18th-century accounts describe menstrual lodges for seclusion, yet women often traveled or hunted during cycles, contradicting European colonial exaggerations of total isolation; blood was sometimes seen as spiritually potent rather than solely defiling.^[120] In ancient and historical Chinese contexts, Confucian and Taoist influences barred menstruating women from sacred rituals or statue contact, equating blood with yin imbalance and uncleanliness, while hygiene used cloth pads or free absorption.^[121] Anthropological surveys indicate taboos' prevalence correlates with patrilineal societies and agricultural economies, where blood's perceived fertility-disrupting potential prompted avoidance rituals, though hunter-gatherer groups like certain Australian Aboriginals treated menstruation neutrally or positively without seclusion.^[122] In sub-Saharan African and Pacific Islander cultures, practices varied from using banana fibers or leaves for absorption to communal support without stigma, but colonial records often amplified impurity narratives to justify missionary interventions.^[123] These patterns highlight causal links between menstrual visibility—tied to blood's biological messiness—and cultural mechanisms for social order, rather than inherent "uncleanness," with empirical hygiene limited by pre-industrial materials across regions.^[115]

Rationales for Taboos and Seclusion

In numerous traditional societies, menstrual taboos and seclusion have been rationalized through beliefs in the ritual impurity or contaminating potency of menstrual blood, posited to defile food, water, sacred sites, or individuals upon contact. Among the Ufipa people of Tanzania, as documented in ethnographic studies, menstrual blood is conceptualized as a powerful substance capable of both cleansing and polluting, necessitating women's isolation from communal cooking and agricultural activities to avert crop failure or illness in others. Similarly, in Hindu-influenced practices in Nepal, the chhaupadi tradition requires women to reside in isolated huts during menstruation to contain this impurity, drawing from scriptural interpretations that associate the blood with temporary untouchability, thereby preserving household purity and familial well-being. These rationales, while varying by cultural context, often stem from pre-scientific understandings of blood as a vital yet hazardous fluid, though contemporary analyses highlight their reinforcement through patriarchal structures rather than verifiable sanitary mechanisms.^[124] A secondary rationale emphasizes protection for the menstruating woman herself, framing seclusion as a provision of respite during physiological discomfort, fatigue, or vulnerability to exertion. Ethnographic accounts from hunter-gatherer groups suggest that periodic withdrawal from labor-intensive tasks like foraging allowed recovery from blood loss and cramps, potentially enhancing reproductive fitness by minimizing risks of injury or overexertion in a period of reduced strength. Proponents of this view, including examinations of indigenous practices, argue that such arrangements originally fostered group solidarity, with synchronized cycles enabling collective non-reproductive phases for cooperative endeavors, though empirical validation of menstrual synchrony as a widespread adaptive trait is contested due to small sample sizes and environmental confounders in observational data. In contrast, evolutionary hypotheses like those advanced by Chris Knight link taboos to enforced sexual abstinence, theorizing it maintained cycle alignment for synchronized group hunting among early hominids, but this remains speculative without fossil or genetic corroboration.^[125]^[126] Additional rationales invoke the blood's symbolic association with life-death cycles or supernatural forces, warranting seclusion to harness or neutralize its influence. In some African and Oceanic cultures, menstrual blood is attributed magical properties—either curative or destructive—prompting isolation to prevent unintended harm, such as souring milk or wilting plants, as observed in cross-cultural anthropological surveys. These explanations, while empirically ungrounded in modern microbiology, may reflect intuitive recognition of bodily fluids' pathogen-carrying potential in eras lacking disinfection, where contact with open blood could facilitate transmission of infections like hepatitis via shared utensils or wounds; however, direct historical linkages between such awareness and taboos are inferential rather than documented. Where taboos persist, they often prioritize symbolic order over evidence-based hygiene, occasionally exacerbating health risks like malnutrition or exposure during seclusion.^[124]^[127]

Debunked Myths and Empirical Realities

One persistent myth holds that women living in close proximity, such as roommates or family members, synchronize their menstrual cycles due to pheromones or social cues. Empirical studies, including reanalyses of dormitory data and longitudinal tracking of cohabiting pairs, have found no statistical evidence for this phenomenon, attributing apparent alignments to chance convergence within the limited 28-day cycle window rather than causal mechanisms.^[128] ^[129] Another common belief is that premenstrual syndrome (PMS) symptoms are primarily psychological or exaggerated for behavioral excuses, dismissing them as non-biological. In reality, PMS involves verifiable somatic and affective changes tied to luteal-phase progesterone and estrogen fluctuations, with neuroimaging and hormonal assays showing altered brain activity in emotion-regulation regions; approximately 75-90% of menstruating women experience these, with severe variants like PMDD affecting 3-8% and responsive to targeted interventions like SSRIs.^[130] ^[131] Academic sources on PMS have occasionally downplayed hormonal causality in favor of psychosocial models, but prospective daily-rating studies confirm cyclicity exceeds placebo effects or reporting biases.^[34] The notion that menstrual blood loss is copious or debilitating for most women—often portrayed as equivalent to significant hemorrhage—is overstated. Controlled studies using alkaline hematin assays quantify average blood loss at 30-40 mL per cycle (total fluid ~70-80 mL), equivalent to a few tablespoons, with heavy menstrual bleeding defined as exceeding 80 mL and affecting only 10-30% of cases; this volume rarely causes anemia in iron-replete individuals absent underlying pathology.^[132] ^[133] Claims that physical exertion during menstruation risks harm or diminishes performance lack substantiation and contradict evidence. Meta-analyses indicate exercise, including aerobic and resistance training, reduces dysmenorrhea intensity by up to 50% via endorphin release and improved pelvic circulation, with no phase-specific decrements in strength or endurance in eumenorrheic women; cycle-phase performance variations are minimal (<5%) and often attributable to individual factors like hydration rather than estrogen/progesterone alone.^[134] ^[135] ^[136] Dietary restrictions, such as avoiding cold foods or dairy to prevent flow disruptions, stem from cultural folklore without physiological basis. Randomized trials and nutritional epidemiology find no causal links between specific ingestions and cycle parameters, as menstrual flow is governed by endometrial shedding independent of transient dietary effects beyond caloric deficits potentially delaying ovulation.^[137]

Controversies and Policy Debates

Menstrual Equity and Period Poverty Claims

Advocates for menstrual equity assert that systemic barriers, including the cost of disposable products and taxation, exacerbate inequalities for those who menstruate, necessitating policies such as free provision in public facilities, schools, and workplaces, as well as exemptions from sales taxes on menstrual items.^[138] These efforts gained traction in the late 2010s, with examples including Scotland's 2021 legislation mandating free products in public buildings and U.S. states like New York removing the "tampon tax" by 2022.^[139] Claims of period poverty frame the issue as a public health crisis, positing that unaffordable products lead to missed school days, reduced productivity, and health risks like infections from improvised alternatives.^[140] Survey-based evidence in developed countries reports varying degrees of access challenges, often concentrated among low-income or marginalized groups. In the United States, a 2019 national survey of teens aged 13-19 found 20% experienced trouble affording or accessing products at least once in the prior year, rising to 1 in 3 adults in some estimates from advocacy-led polls.^[139]^[141] In the United Kingdom, a 2020 Plan International survey indicated 3 in 10 girls aged 14-21 struggled with affordability or access, with similar self-reported rates during economic disruptions like the COVID-19 quarantine.^[142]^[140] A 2024 U.S. pediatric emergency department study reported 1 in 3 adolescent patients cited difficulties obtaining products.^[143] Proponents link these figures to broader outcomes, such as 16.9 million U.S. menstruating individuals in poverty facing compounded food insecurity.^[144] However, empirical scrutiny reveals limitations in these claims' scope and causality. Menstrual product costs average $20 per cycle or $66-84 annually for disposables in high-income settings, equating to under 0.2% of median female earnings in states like Colorado.^[145]^[146] Such expenditures represent a minor share relative to overall household budgets, suggesting period poverty primarily manifests among the most economically vulnerable rather than as a widespread phenomenon independent of general deprivation.^[147] Many surveys rely on self-reported "struggles," which may encompass temporary or perceived barriers rather than outright inability, and originate from advocacy organizations potentially incentivized to highlight deficits.^[148] Policy responses like free distribution have shown mixed uptake, with studies indicating low preference for reusables among recipients and questions about long-term efficacy versus addressing root poverty drivers.^[149] Critiques of the narrative emphasize opportunity costs and unintended effects, arguing that earmarked menstrual programs divert resources from universal welfare supports while framing a solvable hygiene issue as an identity-specific injustice.^[150] In high-income contexts, anecdotal drivers underpin much policy momentum, with limited rigorous longitudinal data linking product access to claimed educational or economic harms after controlling for socioeconomic confounders.^[148] Where period poverty occurs, it correlates strongly with intersecting factors like homelessness or incarceration, underscoring that targeted equity claims risk oversimplifying causal realities rooted in broader economic inequities.^[138]

Workplace Accommodations and Biological Realism

Menstruation imposes biological constraints on female productivity due to symptoms such as dysmenorrhea, which affects 45-95% of menstruating women and often leads to reduced focus and performance.^[151] Severe cases, reported in 30% of affected women, correlate with absenteeism rates of 13-39% and presenteeism in 64-96% of instances, where individuals attend work but operate at diminished capacity.^[152]^[153] Presenteeism contributes more substantially to overall productivity loss than absenteeism, as symptoms like pain and fatigue persist without full work disruption.^[154] These biological effects translate to measurable economic burdens on employers, with annual costs from menstrual disorders estimated at $8.6 billion in the United States, 72% attributable to productivity reductions.^[155] In the United Kingdom, absences and impairments from painful periods and related conditions cost £11 billion yearly, while Australia faces $14 billion in losses from similar issues.^[156]^[157] Such data underscore the causal link between female-specific reproductive physiology and workforce inefficiencies, necessitating accommodations grounded in empirical symptom severity rather than generalized equity claims. Workplace accommodations for menstruation typically include paid leave options, flexible scheduling, or access to private facilities, implemented in countries like Japan (since 1947), Indonesia, South Korea, Taiwan, Vietnam, Zambia, and Spain (from 2023).^[158]^[159] These policies limit leave to 1-3 days per cycle, often unpaid or optional, aiming to mitigate acute symptoms without broad disruption.^[160] However, uptake remains low; in Japan, women average only 0.9 days of menstrual leave annually, indicating that biological resilience, pain management strategies, or cultural preferences for discretion often suffice without formal invocation.^[161] Biological realism demands that accommodations prioritize verifiable causal impacts—such as targeted support for severe dysmenorrhea cases—over universal mandates that risk stigmatizing menstruation as inherent weakness or inflating administrative costs without proportional gains.^[162] Evidence of limited policy utilization suggests many women adapt to cyclical impairments through individual means, aligning with historical norms where sex-specific biology was accommodated pragmatically rather than through expansive entitlements.^[161] Policies ignoring this variability, or those influenced by advocacy disconnected from uptake data, may exacerbate perceptions of female fragility, potentially deterring hiring in competitive sectors.^[163]

Gender and Biological Determinism in Discourse

Biological determinism frames menstruation as a physiological process inextricably linked to female sex, governed by genetic (primarily XX chromosomes), hormonal (estrogen and progesterone cycles), and anatomical factors (ovaries, uterus, and endometrium) that enable the buildup and shedding of uterine lining in the absence of pregnancy.^[2] This perspective emphasizes causal mechanisms rooted in reproductive biology, where ovulation triggers endometrial proliferation, and the lack of implantation leads to menstrual flow, a trait evolved in humans and select mammals for efficient pregnancy preparation.^[1] Empirical studies confirm these processes occur exclusively in individuals with functional female reproductive tracts, underscoring sex-specific determinism over social or identity-based constructs.^[164] In contemporary discourse, particularly within gender studies and advocacy, biological determinism faces challenges from ideologies prioritizing gender identity over sex, prompting shifts to terms like "people who menstruate" or "menstruators" to encompass transgender men and non-binary individuals who retain female anatomy post-transition.^[165] This linguistic reframing, evident in campaigns and media since the mid-2010s, seeks inclusivity but has drawn criticism for obscuring the immutable biological prerequisites of menstruation, which cannot manifest in those without ovaries or a uterus, irrespective of self-identified gender.^[166] For example, in 2020, author J.K. Rowling questioned the erasure of "women" in such phrasing, arguing it dilutes recognition of sex-based realities amid broader debates on reproductive health policy and single-sex spaces.^[166] Proponents of gender-neutral language, often aligned with institutional frameworks in academia and NGOs, contend it mitigates stigma for gender-diverse groups, yet biological evidence remains unaltered: no peer-reviewed data supports menstruation in biological males, even with hormone therapies, as these do not replicate ovarian cyclicity or endometrial response.^[167] Critics, including biologists and sex-based rights advocates, highlight how such discourse can complicate clinical research and public health messaging, where precise sex-differentiated data—such as menstrual cycle impacts on vaccine responses or athletic performance—are essential for accuracy.^[168]^[135] This tension reflects broader ideological pressures, where sources favoring inclusivity may underemphasize deterministic biology, potentially at odds with empirical causal chains in reproductive physiology.^[169]

Recent Developments in Research

Advances in Menstrual Health Studies (Post-2020)

Post-2020 research has increasingly positioned the menstrual cycle as a vital sign for broader health monitoring, with studies demonstrating its utility in predicting chronic conditions such as cardiovascular disease and diabetes. A 2025 Lancet review emphasized that cycle length irregularities correlate with elevated risks of premature mortality and gynecologic disorders, advocating for routine tracking in clinical practice to enable early intervention.^[170] Large-scale longitudinal efforts, including the Apple Women's Health Study launched in 2020 and updated through 2025, have analyzed self-reported data from over 100,000 participants, revealing associations between cycle variability and factors like age, BMI, and hormonal contraceptives, thereby advancing epidemiological insights into cycle dynamics as indicators of systemic health.^[171] Empirical investigations into menstrual disruptions following SARS-CoV-2 infection and vaccination have yielded consistent findings of temporary cycle alterations, typically resolving within one to two cycles. A 2024 analysis of unvaccinated participants with COVID-19 reported a mean 1.45-day increase in cycle length compared to pre-event baselines, attributed to inflammatory immune responses affecting hypothalamic-pituitary-ovarian axis function.^[172] Similarly, multiple cohort studies, including those from the Apple Women's Health Study, documented heavier bleeding and prolonged cycles post-vaccination in approximately 20-30% of reproductive-age women, with odds ratios for changes ranging from 1.2 to 1.8, though no long-term fertility impacts were observed.^[173]^[174] These effects highlight the menstrual cycle's sensitivity to acute stressors, informing causal models of immune-endocrine interactions without evidence of permanent harm.^[175] Advances in endometriosis research have focused on diagnostic precision and targeted therapies, leveraging big data and imaging innovations. A 2025 UCSF study utilized genomic and phenotypic datasets from thousands of patients to identify biomarkers accelerating diagnosis from years to months, addressing historical delays due to symptom overlap with other conditions.^[176] Non-surgical options, including immunomodulatory drugs inspired by cancer therapies, showed promise in phase II trials for reducing lesion growth via inhibition of inflammatory checkpoints, with preclinical models confirming efficacy in suppressing ectopic endometrial proliferation.^[177] Enhanced MRI techniques and AI-assisted laparoscopy, reported in 2024 reviews, improved detection rates by 40-50% for deep infiltrating lesions, facilitating personalized treatment plans that minimize surgical recurrence.^[178] For premenstrual dysphoric disorder (PMDD), neurosteroid modulators have emerged as novel interventions targeting allopregnanolone dysregulation. Phase II trials of sepranolone, administered subcutaneously in the luteal phase, reduced core PMDD symptoms by 25-30% versus placebo, outperforming traditional SSRIs in rapidity of onset due to direct GABA-A receptor agonism.^[179] Complementary research on synthetic allopregnanolone analogs demonstrated sustained mood stabilization in luteal-phase dosing, with meta-analyses confirming hormonal therapies' superiority over continuous progestins for symptom relief without exacerbating physical PMS.^[180] Internet-delivered cognitive behavioral therapy incorporating emotion regulation, evaluated in 2025 randomized trials, yielded moderate effect sizes (Cohen's d ≈ 0.6) for reducing irritability and anxiety, offering scalable alternatives to pharmacotherapy.^[181] Physiological studies have clarified cycle-phase influences on performance and immunity, debunking exaggerated claims while affirming modest effects. A 2025 meta-analysis of cognitive tasks found no significant fluctuations across phases, contradicting prior anecdotal reports and attributing perceived changes to expectancy biases rather than hormonal causality.^[182] In contrast, athletic research documented 5-10% variations in strength and endurance during the luteal phase, linked to elevated progesterone's impact on thermoregulation and substrate utilization, with implications for training optimization.^[183] Immune profiling revealed cyclic shifts in T-cell activation and cytokine profiles, with follicular-phase advantages in vaccine responses, as evidenced by post-2020 influenza and COVID-19 immunogenicity data.^[184] These findings underscore the cycle's role in modulating recovery and stress adaptation, prioritizing empirical measurement over narrative-driven interpretations.^[185]

Gaps in Clinical and Epidemiological Data

Despite regulatory changes such as the 1993 FDA guidelines mandating inclusion of women in clinical trials, menstruating individuals continue to be underrepresented in biomedical research, with studies from 1970 to 2019 showing persistent gaps in trial participation, particularly for non-reproductive endpoints.^[186]^[187] This exclusion stems from concerns over menstrual cycle variability confounding results, leading to insufficient data on how pharmaceuticals and interventions interact with hormonal fluctuations, as evidenced by ongoing disparities where women's health conditions like endometriosis receive funding 20-50 times lower relative to disease burden compared to male-dominated equivalents.^[188]^[189] Epidemiological studies on menstrual cycles heavily rely on self-reported data from apps and surveys, introducing recall bias and selection effects, as participants contributing multiple cycles are overrepresented, skewing patterns toward regular users who may differ demographically from the broader population.^[190]^[191] For instance, large cohort analyses reveal cycle length variations by ethnicity—1.6 days longer on average for Asian participants and 0.7 days for Hispanic—but these findings are limited by unverified self-reports and underrepresentation of low-income or non-Western groups, hindering generalizability.^[191] Longitudinal data across the reproductive lifespan remains sparse, with most research focusing on ages 18-40, understudying perimenopausal transitions or adolescent irregularities linked to cardiovascular risks.^[76]^[192] Clinical gaps persist in evaluating menstrual technologies and disorders; a 2023 review identified deficiencies in standardized outcome measures for products like cups and tampons, with few randomized trials assessing efficacy, safety, or long-term health impacts beyond basic absorption.^[193] Prevalence estimates for conditions such as dysmenorrhea and irregular cycles vary widely (e.g., 27% for irregularity in some cohorts), but diagnostic delays average 7-10 years due to inconsistent epidemiological tracking and underintegration into primary care.^[194]^[195] Emerging factors like air pollution's endocrine-disrupting effects on cycle length show promise in small studies but lack robust, population-level confirmation, underscoring needs for causal analyses over correlational data.^[196] Global epidemiological voids are pronounced in low-resource settings, where menstrual health data is neglected in development agendas despite affecting productivity and hygiene access for billions, with only 39% of schools worldwide providing adequate support as of 2024.^[197]^[198] Understudied demographics, including transgender individuals on hormone therapies or ethnic minorities, further limit insights, as highlighted by initiatives like Stanford's 2025 Oura Ring study targeting these groups.^[199] Addressing these requires standardized biomarkers, diverse cohorts, and interdisciplinary integration to move beyond historical taboos and funding biases.^[200]^[201]

References

[1]
Menstruation: science and society - PMC - PubMed Central
Menstruation is defined as the shedding of the upper (the so-called “functionalis”) layer of the uterine lining after the luteal phase of the ovarian cycle.
[2]
Physiology, Menstrual Cycle - StatPearls - NCBI Bookshelf
Sep 27, 2024 · The female reproductive system, unlike the male, undergoes regular cyclic changes known as the menstrual cycle, which serves as the body's periodic preparation ...
[3]
Menstrual Cycle Length and Patterns in a Global Cohort of Women ...
Jun 24, 2020 · In over 600,000 cycles collected using the Natural Cycles app, the mean cycle length was 29.3 (SD 5.2) days [4], and in 225,596 cycles, the mean ...Missing: empirical | Show results with:empirical
[4]
Menstrual Cycle (Normal Menstruation): Overview & Phases
A normal menstrual cycle can last between 21 and 35 days. You can expect to bleed between three and seven days each time you get your period.Missing: empirical data
[5]
The Normal Menstrual Cycle and the Control of Ovulation - NCBI - NIH
Aug 5, 2018 · Menstruation is the cyclic, orderly sloughing of the uterine lining, in response to the interactions of hormones produced by the hypothalamus, ...
[6]
Menstruation in Girls and Adolescents: Using the Menstrual Cycle as ...
By including an evaluation of the menstrual cycle as an additional vital sign, clinicians reinforce its importance in assessing overall health status.<|separator|>
[7]
Study suggests a new explanation for menstruation
Dec 15, 2006 · Finally, Strassmann points out, if menstruation evolved to protect the uterus against bacteria delivered by sperm, then species in which females ...
[8]
The Evolution of Endometrial Cycles and Menstruation
According to a recent hypthesis, menstruation evolved to protect the uterus oviducts from sperm-borne pathogens by dislodging infected endometrial tissue ...
[9]
Menstrual Cycle - Women's Health Issues - Merck Manuals
Menstruation is the shedding of the lining of the uterus (endometrium) accompanied by bleeding. It occurs in approximately monthly cycles throughout a ...
[10]
Why do only some animals have periods? - Live Science
Aug 10, 2024 · Scientists know of around 85 mammal species, or less than 2% of mammals, that have a menstrual cycle. Most of these are primates.
[11]
The evolution of menstruation: A new model for genetic assimilation
There is clear evidence that at least one species in each of the genera Cebus, Ateles, Alouatta, and Lagothrix exhibits menstruation [4–7]. For other New World ...
[12]
Characteristics of the endometrium in menstruating species
Mar 4, 2020 · Besides in primates, menstruation has been observed only in the spiny mouse [3], 3–5 species of bats [4–6], and the elephant shrews [7] (Figure ...
[13]
Monkeys, mice and menses: the bloody anomaly of the spiny mouse
Jan 5, 2019 · In fact, approximately 98% of all mammalian species do not menstruate [1]. Menses is almost exclusively restricted to higher order primates, ...
[14]
How did menstruation evolve? | Max Delbrück Center
Jul 21, 2021 · Yet only a few mammals have a menstrual cycle. As well as the higher primates, including humans, it only occurs in certain bat species and the ...
[15]
Periods and fertility in the menstrual cycle - NHS
Periods last around 2 to 7 days, and women lose about 20 to 90ml (about 1 to 5 tablespoons) of blood in a period. Some women bleed more heavily than this, but ...
[16]
Real-world menstrual cycle characteristics of more than ... - NIH
Aug 27, 2019 · The menstrual cycle begins and ends with menstruation and is divided by ovulation into the follicular and luteal phases. The fertile window ...
[17]
Physiology of the Endometrium and Regulation of Menstruation
The physiological functions of the uterine endometrium (uterine lining) are preparation for implantation, maintenance of pregnancy if implantation occurs, and ...
[18]
The Menstrual Endometrium: From Physiology to Future Treatments
Jan 30, 2022 · MMPs are widely accepted as being responsible for the shedding of the upper layers of the endometrium during menses (18), although the ...
[19]
Physiology of the Endometrium and Regulation of Menstruation
Jul 1, 2020 · The physiological events of menstruation and endometrial repair provide an accessible in vivo human model of inflammation and tissue repair.
[20]
Menstrual Bleeding Patterns Among Regularly Menstruating Women
Women bled for a median of 5 days during menstruation, with the first 3 days typically reported as heavier bleeding. Anovulatory cycles were followed by ...
[21]
The Duration of Menstrual Blood Loss: Historical to Current ... - MDPI
Fewer than 5% of women had a <4-day average duration of bleeding and only 5% had bleeding averaging 8 days. The duration of bleeding varied little for ...
[22]
Menstrual cycle: What's normal, what's not - Mayo Clinic
Apr 22, 2023 · The cycle isn't the same for everyone. Menstrual bleeding might happen every 21 to 35 days and last 2 to 7 days. For the first few years after ...
[23]
Menstrual cycle length and modern living: a review - PMC - NIH
MCL is sensitive to inputs from the environment and varies within and between individuals [2], though a length between 24 and 38 days is considered normal [3].
[24]
how menstrual cycles vary by age, weight, race, and ethnicity
We found that people's menstrual cycle lengths varied by on average 4 to 11 days depending on age. For instance, for people under 20 years old, menstrual cycle ...Missing: empirical | Show results with:empirical
[25]
Proteomic Analysis of Menstrual Blood - PMC - NIH
Menstruation is the expulsion of the endometrial lining of the uterus following a nearly month long preparation for embryo implantation and pregnancy.
[26]
The composition of menstrual fluid, its applications, and recent ...
May 29, 2024 · Menstrual blood consists of 3 main components: blood, vaginal fluid with mucus, and cells and fluid from shedding late secretory phase ...
[27]
How Much Blood Do You Lose on Your Period? - Healthline
May 30, 2018 · It's widely accepted that the average person loses between 30 and 40 milliliters, or two to three tablespoons, of blood during menstruation.
[28]
How much period blood is normal? - Clue app
Everybody is different, but the 'typical' amount of blood lost during your period is between 5-80 mL. 400 mL is considered a lot of blood to lose during your ...
[29]
Innovative Hematology Analysis Using Menstrual Blood
Aug 5, 2024 · Menstrual blood consists mostly of arterial blood and 25% venous blood. It contains prostaglandins, tissue debris, and substantial amounts of ...
[30]
Dysmenorrhea - AAFP
Dysmenorrhea occurs in 50% to 90% of adolescent girls and women of reproductive age and is a leading cause of absenteeism. Secondary dysmenorrhea as a result of ...
[31]
Dysmenorrhea: Background, Pathophysiology, Etiology
Apr 10, 2025 · A study of 408 young Italian women found that the prevalence of dysmenorrhea was 84.1% when only menstrual pain was considered, 55.2% when ...
[32]
Mood symptoms and gut function across the menstrual cycle in ...
Gastrointestinal (GI) symptoms such as bloating, constipation, and nausea are common in the days before menstruation, experienced by as many as 73 % of ...<|separator|>
[33]
Premenstrual syndrome (PMS) - Symptoms & causes - Mayo Clinic
Premenstrual syndrome (PMS) has a wide variety of signs and symptoms, including mood swings, tender breasts, food cravings, fatigue, irritability and ...
[34]
Premenstrual syndrome: new insights into etiology and review of ...
The most common mental symptoms of PMS include irritability, tearfulness, anxiety, and depressed mood. Physical ones, on the other hand, mainly involve ...Hormone treatment · Herbal treatment · Alternative treatment · Surgical treatment<|separator|>
[35]
Premenstrual Syndrome and Premenstrual Dysphoric Disorder - AAFP
Aug 1, 2016 · Premenstrual disorders affect up to 12% of women. The subspecialties of psychiatry and gynecology have developed overlapping but distinct ...Abstract · Epidemiology · Etiology · Diagnosis
[36]
Variance in Mood Symptoms Across Menstrual Cycles - NIH
Jul 10, 2017 · The majority of variance (79%–98%) was due to daily fluctuations and did not conform to a standard pattern of premenstrual rise/postmenstrual ...
[37]
Factors associated with regularity and length of menstrual cycle
Sep 1, 2022 · The study suggests that irregular and long menstrual cycles are associated with reproductive, lifestyle, and occupational factors; also with menstrual distress ...
[38]
Factors associated with regularity and length of menstrual cycle
Sep 1, 2022 · The study suggests that irregular and long menstrual cycles are associated with reproductive, lifestyle, and occupational factors; also with ...
[39]
The evolution of endometrial cycles and menstruation - PubMed
According to a recent hypothesis, menstruation evolved to protect the uterus and oviducts from sperm-borne pathogens by dislodging infected endometrial tissue.
[40]
[PDF] Energy Economy in the Evolution of Menstruation
45 Assuming that menstruation was also a rare event in ancestral populations, it is doubtful that it evolved as a defense against pathogens. Prediction 3. In ...
[41]
The evolution of menstruation: a new model for genetic assimilation
We argue that decidualization became genetically stabilized in menstruating lineages, allowing females to prepare for pregnancy without any signal from the ...Missing: theory | Show results with:theory
[42]
Explainer: why do women menstruate? - The Conversation
Jun 17, 2013 · A more plausible explanation for menstruation is that it evolved to accommodate the peculiar way in which human embryos embed into the lining of the uterus.
[43]
The significance and evolution of menstruation - PubMed
The evolutionary origins of menstruation have been based on two theories: the ability to eliminate infectious agents carried to the uterus with spermatozoa.
[44]
Evolution, the Menstrual Cycle, and Theoretical Overreach
Jun 15, 2020 · For theoretical reasons, research testing evolutionary models of menstrual-cycle-related behavior change has focused on proximity to ovulation ...
[45]
Estrous and Menstrual Cycles - Illinois Experts
Jan 1, 2018 · The menstrual cycle differs from the estrous cycle in that the follicular phase is significantly longer and there is shedding of the uterine ...
[46]
The Estrous Cycle
The estrous cycle can be divided into four stages: proestrus, estrus, metestrus, and diestrus. During proestrus the CL regresses (progesterone declines) and a ...
[47]
MENSTRUA
Comparison to the estrous cycle. Most aspects of the menstrual cycle are strikingly similar to those of the estrous cycle, with a few exceptions: higher ...
[48]
Comparative histopathology of the estrous or menstrual cycle in ...
May 16, 2016 · There are some species differences such as the time of sex maturation, the length of the estrous or menstrual cycle, the length of the luteal ...
[49]
Dysmenorrhoea and prostaglandins: pharmacological ... - PubMed
The increased amount of prostaglandins induces incoordinate hyperactivity of the uterine muscle resulting in uterine ischaemia and pain.
[50]
Dysmenorrhea: Menstrual Cramps, Causes & Treatments
Menstrual cramps happen when a chemical called prostaglandin makes your uterus contract (tighten up). During menstruation, prostaglandin levels are higher, ...
[51]
Dysmenorrhea: Painful Periods - ACOG
This pain is caused by natural chemicals called prostaglandins that are made in the lining of the uterus. Prostaglandins cause the muscles and blood vessels of ...
[52]
Estimating menstrual blood loss in women with normal ... - PubMed
Blood comprised 48% of total menstrual flow for women with moderately heavy blood loss (>60 mL) and 50% for women with excessive blood loss (>100 mL).
[53]
Female work capacity during the menstrual cycle - PubMed
No change in heart rate or oxygen uptake could be observed over the three phases of the menstrual cycle.
[54]
The prevalence and risk factors of dysmenorrhea - PubMed
The prevalence of dysmenorrhea varies between 16% and 91% in women of reproductive age, with severe pain in 2%-29% of the women studied.
[55]
Dysmenorrhea - PubMed
Nov 12, 2023 · Dysmenorrhea is a common complaint among menstruating patients during their reproductive years. Dysmenorrhea may be associated with significant ...
[56]
Dysmenorrhea and Endometriosis in the Adolescent - ACOG
Although the true prevalence of endometriosis in adolescents is unknown, at least two thirds of adolescent girls with chronic pelvic pain or dysmenorrhea ...
[57]
Causes of menorrhagia - ScienceDirect.com
About 80% of cases of menorrhagia are attributed to dysfunctional uterine bleeding. Fibroids are the most common structural lesion related to heavy menstrual ...Missing: prevalence | Show results with:prevalence
[58]
About Heavy Menstrual Bleeding - CDC
May 15, 2024 · Causes · Growths or tumors of the uterus that are not cancer; these can be called uterine fibroids or polyps. · Cancer of the uterus or cervix.Causes · Testing And Diagnosis · Tests
[59]
Prevalence of Heavy Menstrual Bleeding and Its Associated Factors ...
Jul 12, 2023 · Hormonal imbalance secondary to multiple factors can cause HMB, thus hormonal contraception is one of the recommended first-line treatments to ...
[60]
Amenorrhea: Practice Essentials, Pathophysiology, Etiology
Apr 12, 2024 · The incidence of primary amenorrhea in the United States is less than 1%. ... Each year, approximately 5-7% of menstruating women in the United ...
[61]
Amenorrhea - StatPearls - NCBI Bookshelf - NIH
Feb 25, 2024 · Amenorrhea is the absence of menstruation in a female of reproductive age. Amenorrhea can be classified as either primary or secondary amenorrhea.
[62]
Menstruation Disorders in Adolescents - Medscape Reference
May 8, 2023 · PCOS is the most common endocrine disorder, with a prevalence of 6-10%. It is also the most common cause of irregular menstrual bleeding, ...Background · Etiology · Abnormal Uterine Bleeding<|separator|>
[63]
The prevalence, impairment, impact, and burden of premenstrual ...
Currently it is estimated that 3-8% of women of reproductive age meet strict criteria for premenstrual dysphoric disorder (PMDD).
[64]
New data shows prevalence of Premenstrual Dysphoric Disorder
Jan 30, 2024 · Around 1.6% of women and girls have symptomatic Premenstrual Dysphoric Disorder (PMDD), according to a new review of global studies published ...
[65]
Endometriosis - World Health Organization (WHO)
Oct 15, 2025 · Endometriosis affects an estimated 10% (190 million) of reproductive age women worldwide. Endometriosis is a chronic disease and symptoms ...
[66]
Endometriosis: Epidemiology, Diagnosis and Clinical Management
Endometriosis affects 10–15% of all women of reproductive age [1] and 70% of women with chronic pelvic pain [10]. Unfortunately, for many of these women there ...
[67]
The relationship between heavy menstrual bleeding, iron deficiency ...
Jan 24, 2023 · The symptom of heavy menstrual bleeding is highly prevalent and a major contributor to iron deficiency and its most severe manifestation, iron deficiency ...
[68]
Thyroid hormones and menstrual cycle function in a longitudinal ...
Specifically, hypothyroid women are more likely to experience oligomenorrhea and menorrhagia; and hyperthyroid women are more likely to experience hypomenorrhea ...
[69]
Role of Thyroid Dysfunction in Patients with Menstrual Disorders in ...
The impact of hypothyroidism on the menstrual cycle has been identified since the 1950s and leads to changes in cycle length and blood flow [6].
[70]
Menorrhagia as main presentation sign of severe hypothyroidism in ...
In women with hypothyroidism, different changes in menstrual cycle are reported [5]: the most common form is oligomenorrhea [6] and other manifestations ...
[71]
Treatments for seizures in catamenial (menstrual‐related) epilepsy
Catamenial epilepsy describes a worsening of seizures in relation to the menstrual cycle and may affect around 40% of women with epilepsy.
[72]
Basics about Catamenial Epilepsy
Oct 11, 2016 · Catamenial epilepsy is a gender-specific type of epilepsy in which seizure frequency intensifies during certain phases of the menstrual cycle.
[73]
Menstrual Migraines (Hormone Headaches) - Cleveland Clinic
Period headaches are migraines that happen around the time of your menstrual cycle. Symptoms include pain, light sensitivity and tiredness.
[74]
Menstrual Migraine Treatment and Prevention | AMF
Menstrual migraine is caused by the rapid drop in estrogen levels that occurs just prior to your period. “I have patients that tell me, 'Aren't headaches a part ...
[75]
Associations of Menstrual Cycle Regularity and Length With ...
May 24, 2023 · Another prospective study of 13 534 female participants found that women with irregular menstrual cycles had 20% higher risk of heart disease.
[76]
Menstrual Cycle Regularity and Length Across the Reproductive ...
Oct 25, 2022 · In this cohort study of 80 630 women, irregular and long menstrual cycles across the reproductive lifespan were associated with an increased risk of CVD.
[77]
Association of heavy menstrual bleeding with cardiovascular ...
May 23, 2024 · Heavy menstrual bleeding (HMB) is a common menstrual disorder associated with multiple risk factors of cardiovascular disease (CVD) in women.<|separator|>
[78]
Long Menstrual Cycle Is Associated with Type 2 Diabetes Mellitus in ...
Having a long menstrual cycle could be a risk factor for the development of type 2 diabetes, especially in obese women.
[79]
Menstrual Cycle Characteristics, Lifestyle Factors, and Risk of Type ...
Dec 21, 2020 · Importance Menstrual cycle dysfunction is associated with insulin resistance, a key feature early in the pathogenesis of type 2 diabetes.
[80]
The Effect of the Menstrual Cycle on Glucose Control in Women With ...
The current study evaluated the effect of the menstrual cycle on glucose control in six patients with type 1 diabetes, with a median age 23 years and regular ...
[81]
The impact of autoimmune disease on women
Nov 29, 2023 · These findings suggest that underlying changes in hormone levels during the menstrual cycle may impact inflammation and disease activity.
[82]
Menstruation and Lupus - LupusCorner
Because changing hormone levels effect the immune system in a big way, menstruation cycles, also known as periods, can seriously effect lupus symptoms.
[83]
Immunology and the menstrual cycle - PubMed
The menstrual cycle might affect immune cell numbers and modulate their activity throughout the 4-week cycle, as demonstrated in the case of regulatory T cells ...
[84]
The association between premenstrual dysphoric disorder and ...
All but one study found a positive association between PMDD and history or current depression. Many studies found that a history of depression (no current ...
[85]
PMS & PMDD - MGH Center for Women's Mental Health
The major risk factors for PMDD include personal history of a mood or anxiety disorder, family history of premenstrual mood dysregulation, stress and age in ...
[86]
Healthy Habits: Menstrual Hygiene - CDC
May 7, 2024 · Using menstrual products You can choose many types of menstrual products to absorb or collect blood during your period, including sanitary pads ...
[87]
How Often Should You Change Your Pad? - Healthline
Dec 15, 2020 · The American College of Obstetricians and Gynecologists (ACOG) recommends changing your pad at least every 4 to 8 hours, but that's just a very general range.Signs it's time · Per day · Pad types
[88]
Historical Perspectives Reduced Incidence of Menstrual Toxic ...
The CDC study also found that continuous use of tampons was associated with a higher risk of TSS than was alternating use of tampons and other menstrual ...
[89]
Association of characteristics of tampon use with menstrual toxic ...
Indirect evidence suggests that tampon misuse could be associated with an increased risk of menstrual toxic shock syndrome (MTSS). The aim of this study was to ...
[90]
Menstrual cup and risk of IUD expulsion – a systematic review
Jan 21, 2023 · There is a possible association between menstrual cup use and increased risk of IUD expulsion and this information should be shared with patients.
[91]
Menstrual products: A comparable Life Cycle Assessment
Reusable menstrual products have significantly lower environmental impacts than disposable ones. •. Disposable organic products have higher environmental ...
[92]
A systematic review and meta-analysis of reusable menstrual pads ...
The study reported that the RMPs dried faster than cloth, and users were less likely to wear damp RMPs compared to cloth-users [24]. RMP-users were more likely ...
[93]
Environmental impact of menstrual hygiene products - PMC - NIH
In Europe and the United States of America, over 80% of menstrual products end up in landfills, where disposable pads may take 500–800 years to break down. Pads ...
[94]
Use of Menstrual Sanitary Products in Women of Reproductive Age
The most common types of menstrual hygiene products used were disposable menstrual pads (89.0%), followed by cloth menstrual pads (4.5%), and tampons (4.2%).
[95]
General Approaches to Medical Management of Menstrual ... - ACOG
Progestin-only hormonal medications (progestin-only pills, injections, implants, and IUDs) can be used for menstrual suppression. The most common adverse effect ...
[96]
Menstrual suppression: current perspectives - PMC - NIH
Clinicians have used hormonal therapy to suppress menstruation since combination birth control pills were initially developed. Continuous hormonal therapy ...
[97]
Delaying your period with hormonal birth control - Mayo Clinic
You can delay or prevent periods with extended or continuous use of estrogen and progestin or progestin-only birth control pills.
[98]
What to Know About Skipping Periods With Birth Control - ACOG
Using birth control pills and rings to skip periods is safe. Skipping periods is safe if you can use birth control pills or a vaginal birth control ring.
[99]
Hormonal contraception for menstrual suppression - UpToDate
Combined estrogen-progestin methods · Progestin-only methods · - First tier · Depot medroxyprogesterone acetate · Levonorgestrel intrauterine device (LNG 52 mg).
[100]
Highlights of prescribing information: Depo-Provera CI ... - Pfizer
In clinical studies of Depo-Provera CI, by month 12 amenorrhea was reported by 55% of women, and by month 24, amenorrhea was reported by 68% of women using ...<|control11|><|separator|>
[101]
Hormonal IUD (Mirena) - Mayo Clinic
Apr 11, 2024 · After three or more months of using Mirena, you might bleed less during your period. About 20% of people who use Mirena stop having periods ...
[102]
Menstrual Suppression - StatPearls - NCBI Bookshelf - NIH
Jun 7, 2024 · Medication-induced secondary amenorrhea involves the intentional use of hormonal contraceptive medications to suppress menstruation or induce amenorrhea.
[103]
Hormonal Contraception and Bone Health in Adolescents - Frontiers
Aug 20, 2020 · Use of these medications has been associated with slower accrual of bone mineral density (BMD) and increased fracture risk in some studies.
[104]
Hormonal contraception's effect on adolescent bone health
Oct 4, 2022 · Of note, studies show that BM loss is most significant in the first year of use and is at least partially reversible following DMPA cessation.<|separator|>
[105]
Estrogen, progestin, and beyond: thrombotic risk and contraceptive ...
Dec 6, 2024 · Hormonal contraceptive therapy (estrogens and/or progestogens) includes different formulations associated with varying venous thromboembolism (VTE) risks.
[106]
New study adds to evidence of stroke and heart attack risk with ...
The progestin-only intrauterine system was the only hormonal contraceptive not linked to an increased risk, making this option safer for cardiovascular health.<|separator|>
[107]
Progestin-Only Hormonal Birth Control: Pill and Injection - ACOG
Unlike birth control pills that contain estrogen and progestin, progestin-only pills do not increase the risk of high blood pressure or cardiovascular disease.
[108]
Oral Contraceptives and Hypertension Risk: Implications for ...
Sep 30, 2025 · Progestin-only pills are linked to negligible alterations in blood pressure, rendering them a favorable choice for women with elevated ...
[109]
Perspectives on the side effects of hormonal contraceptives among ...
Aug 18, 2023 · In the current study, the main side effects highlighted by participants were headaches, lower abdominal/ back pain, cramps, excessive or ...
[110]
Promoting Improved Access to Tailored Hormonal Contraceptive ...
Tailored CHC regimens do not impact future fertility and menstrual suppression may further reduce the risk of some cancers (Adeyemi-Fowode et al., 2022).
[111]
81 THE MENSTRUAL “TABOO” IN ANCIENT EGYPT* I ... - jstor
The aim of this article is to examine the ancient Egyptian evidence for rules governing the avoidance of contact with menstruating women. As will be seen, this ...
[112]
Did Ancient Egyptians Use Tampons? - Dr. Smiti Nathan
Sep 30, 2024 · This post explores the archaeological record surrounding ancient Egyptian tampons, as well as Egyptian period products and practices.
[113]
What was it like to get your period in ancient Greece?
Nov 1, 2018 · It's certainly possible that women had fewer periods and lighter bleeding, just because their diet was not as good as it is now.
[114]
Menstrual Blood: Uses, Values, and Controls in Ancient Rome
Apr 22, 2022 · According to Pliny the Elder (Natural History, 28, 82), menstruation was used as a liniment to treat superficial abscesses such as erysipelas.
[115]
Cultural aspects and mythologies surrounding menstruation and ...
The objective of this chapter is to present an overview of how menstruation, a normal bodily function, was and is perceived in various ethnic groups and ...
[116]
Getting Your Period in the Middle Ages | Getty News
It involved bog moss, and it's just as uncomfy as you think.
[117]
Feminine Hygiene - Rosalies Medieval Woman
Although there is no concrete proof, it is entirely possible that medieval women used moss-stuffed napkins as sanitary pads. We know that moss is very like a ...Missing: europe | Show results with:europe
[118]
Rituals, Taboos, and Seclusion: Life Stories of Women Navigating ...
Jul 25, 2020 · Drawing from life history narratives of 84 women in Nepal, we examine women's particular lived experiences of cultural rituals, traditions, and taboos ...Introduction · Managing Menstrual Health... · Beliefs, Taboos, and Rituals...
[119]
Banished for menstruating: the Indian women isolated while they ...
Dec 22, 2015 · Women in parts of India are sent to basic huts outside their villages during their periods, as the stigma of menstruation proves hard to overcome.
[120]
“'Periodical Habits': Native American Women, Movement, and ...
Mar 4, 2025 · Eighteenth-century colonists described Native practices of strict seclusion in menstrual huts. Yet Native American women traveled hundreds ...
[121]
The Great Wall around periods: Beliefs and attitudes ... - Sexgenlab
Jan 21, 2019 · In Chinese culture, I was taught to keep periods a secret, make sure all signs were hidden and never talk about it, especially to men. When I ...
[122]
A Cross‐Cultural Study of Menstruation, Menstrual Taboos, and ...
Aug 9, 2025 · Menstrual taboos are pervasive in nature; vary across cultures in terms of severity and laxity depending on socio-cultural variable.
[123]
Socio-cultural implications for women's menstrual health in the ...
Jun 2, 2022 · This paper reviews the social and cultural factors that affect women's ability to effectively manage their menstrual health and hygiene (MHH) in Pacific Island ...
[124]
Menstrual Taboos: Moving Beyond the Curse - NCBI - NIH
Jul 25, 2020 · And, are all menstrual taboos created equal? Gottlieb opens this chapter with an anthropological approach to the nature of “taboo” itself ...
[125]
If the body isn't sacred, nothing is: why menstrual taboos matter
Feb 11, 2017 · Menstrual seclusion was once about giving women a safe space – hunter gatherer cultures can teach us how women's blood is potent, not polluting.
[126]
How did menstruation become taboo? - Clue app
Sep 8, 2017 · The creation of menstrual taboos took place independently and repeatedly across different peoples and geographies. But scholars don't agree ...A Look At The Historical... · The Theory Is Best Explained... · How A Practice That...
[127]
Women's extreme seclusion during menstruation and children's ...
The practice is rooted in patriarchy and Hindu mythology that considers women impure, thus untouchable, during menstruation and childbirth. In addition to ...
[128]
Women do not synchronize their menstrual cycles - PubMed
It is widely believed that women who live together or who are close friends synchronize their menstrual cycles. We reexamined this phenomenon in two ways.
[129]
Do menstrual cycles sync? Unlikely, finds Clue data
From our small pilot study of Clue users, our data scientists found that cycles between pairs and cohabiting individuals did not align. Our statistical evidence ...<|separator|>
[130]
Premenstrual Syndrome - StatPearls - NCBI Bookshelf - NIH
Premenstrual syndrome (PMS) encompasses clinically significant somatic and psychological manifestations during the luteal phase of the menstrual cycle.Introduction · Etiology · Epidemiology · Treatment / Management
[131]
Psychiatric Symptoms Across the Menstrual Cycle in Adult Women
Mar 9, 2022 · Strong evidence indicates increases in psychosis, mania, depression, suicide/suicide attempts, and alcohol use during these phases.
[132]
Menstrual blood loss... What's normal?
Feb 24, 2020 · On average, people who menstruate lose ~ 70-80 ml of fluid (~ 35-40 ml of blood [1]) per period [2]. This amount of fluid would fill a double ...
[133]
Very Heavy Menstrual Flow - CeMCOR
The usual length of menstrual bleeding is four to six days. The usual amount of blood loss per period is 10 to 35 ml. That means it is normal to soak one to ...
[134]
Exercise for dysmenorrhoea - PubMed
Sep 20, 2019 · Exercise versus no treatmentExercise may have a large effect on reducing menstrual pain intensity compared to no exercise (standard mean ...
[135]
Current evidence shows no influence of women's menstrual cycle ...
Mar 22, 2023 · Estrogen levels peak during the late follicular phase before ovulation, while progesterone levels are highest post-ovulation during the mid- ...
[136]
Effects of the menstrual cycle on exercise performance - PubMed
This article reviews the potential effects of the female steroid hormone fluctuations during the menstrual cycle on exercise performance.
[137]
https://www.unicef.org.au/stories/busted-eight-myths-about-periods
[138]
Period Poverty and Promoting Menstrual Equity | JAMA Health Forum
Aug 19, 2021 · More recent evidence highlights how people who menstruate and are experiencing homelessness face challenges that go beyond access to products, ...Missing: critiques | Show results with:critiques
[139]
Period poverty and its reach across the US | Brookings
Nov 27, 2024 · Louis found that 64% were unable to afford period products at least once in the previous 12 months, and 21% of those experiencing this issue ...Missing: prevalence | Show results with:prevalence
[140]
Period Poverty: A Neglected Public Health Issue - PMC - NIH
Period poverty affects not only middle-/low-income and humanitarian crisis countries but also developed countries, as evidenced by the fact that 10% of girls ...Missing: prevalence | Show results with:prevalence
[141]
Period Poverty – why millions of girls and women cannot afford their ...
Jul 28, 2025 · In the United States of America, 1 in 4 teens and 1 in 3 adults struggle to afford period products, especially teens of colour and lower-income ...Missing: prevalence | Show results with:prevalence
[142]
Period poverty: the statistics around the world | ActionAid UK
May 18, 2022 · The World Bank estimates at least 500 million women and girls globally lack access to the facilities they need to manage their periods.
[143]
https://www.aap.org/en/news-room/news-releases-from-aap-conferences/period-poverty-research-finds-1-in-3-teens-lack-access-to-menstruation-products/
[144]
Editorial: Period poverty - PMC - NIH
It is estimated that 16.9 million menstruating women in the United States live in poverty, two-thirds of which are low-income and food-insecure women who cannot ...
[145]
Cost of Having Your Period in Every Country and U.S. State
Jun 5, 2025 · Colorado ranks as the most affordable state, where a month's supply of tampons, sanitary pads, and ibuprofen costs 0.15% of the average person's ...The UK Ranks as the Most... · Colorado is the Most... · People Who Menstruate in...
[146]
How Inflation Impacts the Pink Tax and the Period Product Industry
The average woman spends $20 on feminine hygiene products per menstrual cycle, according to estimates from the National Organization of Women. People who don't ...
[147]
Period poverty in the United States of America: a socio-economic ...
May 17, 2025 · The work of Kelley and Jamieson24 asserts that 20% of teenagers who menstruates in the U.S. had difficulty affording menstrual products. It must ...
[148]
Experiences of menstruation in high income countries: A systematic ...
Jul 21, 2021 · New policies in high income countries (HICs) have responded to anecdotal evidence that many struggle to meet their menstrual health needs.
[149]
An observational study assessing the impact of free little period ...
Dec 16, 2024 · Research on the preference of menstruators using food/diaper/period product banks has reported preference for reusable products is low.Missing: critiques | Show results with:critiques
[150]
[PDF] Law's Ability to Further the "Menstrual Movement"
4 The movement's aims are twofold: First, it wants to increase awareness of menstruation and remove discrimination against those who menstruate, thus achieving.<|control11|><|separator|>
[151]
Menstrual cycle-associated symptoms and workplace productivity in ...
Dec 15, 2022 · Dysmenorrhea, affecting 45–95% of women, has been reported as heavily impacting productivity and focus, often leading to absences from work.
[152]
Effects of dysmenorrhea on work productivity and quality of life in ...
Aug 1, 2025 · In this study cohort, 17.5% of the participants experienced absenteeism and 64.3% experienced presenteeism due to health issues. Notably, the ...
[153]
(PDF) Dysmenorrhea among working women and its effect on their ...
Oct 8, 2025 · Dysmenorrheic working women reported an absenteeism rate of 39.5%, a presenteeism rate of 96.1%, an overall work impairment rate of 96.4%, and ...
[154]
Productivity loss due to menstruation-related symptoms
Jun 27, 2019 · Menstruation-related symptoms cause a great deal of lost productivity, and presenteeism is a bigger contributor to this than absenteeism.
[155]
Association between menstrual disorders and women's workforce ...
Menstrual disorders are associated with reduced workforce participation mainly through reduced work productivity, and increased work absenteeism.
[156]
Women missing work due to painful periods costing UK €13 billion
Oct 5, 2024 · Women missing work due to painful periods, endometriosis, fibroids, and ovarian cysts costs the UK economy £11 billion (€13 billion) a year.
[157]
Problematic periods cost Australians billions each year, research finds
Jan 19, 2025 · The resulting economic burden is estimated to be about $14 billion a year. What's next? Jean Hailes for Women's Health has recommended a review ...
[158]
The Pros and Cons of Menstrual Leave Policies in the Workplace
Jul 30, 2023 · Seven countries now have some form of menstrual leave policy: Spain, Indonesia, Japan, South Korea, Taiwan, Vietnam and Zambia. Each policy is ...Missing: effectiveness | Show results with:effectiveness
[159]
Time Off Work For Menstruation: A Good Idea? by Deborah A. Widiss
May 24, 2023 · In February 2023, Spain became the first European country to guarantee “menstrual leave” for workers, joining several countries, mostly in East ...Missing: evidence | Show results with:evidence
[160]
[PDF] An Analysis of Menstrual Leave as a Legal Workplace Benefit
The countries that successfully passed menstrual leave policies limited leave to either one or two days monthly.61 Italy's bill proposed three days per month,62 ...
[161]
Could 'menstrual leave' change the workplace? - BBC
Apr 28, 2022 · Menstrual leave policies are widely perceived as expensive, however – particularly by critics of these schemes, who often cite employer costs, ...
[162]
Let's talk about it: The controversy surrounding menstrual leave policy
Jul 21, 2025 · The introduction of a menstrual leave policy has significant public health implications for all women in every sector, especially in a country ...
[163]
The controversy behind paid menstrual leave, explained - The Hill
Sep 20, 2022 · Proponents of the measure argue it allows people who menstruate to take optional time off from work without fear of repercussion.
[164]
3 The significance and evolution of menstruation - ScienceDirect.com
Physiologically, menstruation involves complex interactions of inflammation and vascular mechanisms ... endometrium shedding, tissue repair and prevention ...
[165]
Degendering Menstruation: Making Trans Menstruators Matter - NCBI
Jul 25, 2020 · Referring to people who menstruate as 'menstruators' does not come without criticism. ... “Adolescence, Advertising, and the Ideology of ...
[166]
J.K. Rowling accused of transphobia after mocking 'people who ...
Jun 7, 2020 · “'People who menstruate.' I'm sure there used to be a word for those people. Someone help me out. Wumben? Wimpund? Woomud?” Rowling tweeted.
[167]
The science behind periods and gender - Clue app
Apr 12, 2021 · Having a period isn't tied to gender Menstruation is a biological process. It is part of a reproductive system that is largely associated with ...
[168]
Menstruation Is an Afterthought in Research. Here's ... - Ms. Magazine
Jan 23, 2023 · Over half of the world will experience menstruation at some point, yet data on menstruation is not routinely collected in vaccine trials. By ...
[169]
Encyclopedia of Gender and Society - Biological Determinism
Thus, for example, from a strict biological determinist perspective, a woman whose menstrual cycle is irregular or who does not possess fully ...
[170]
The menstrual cycle: a vital sign across the lifespan - The Lancet
Jul 24, 2025 · The menstrual cycle can also serve as a health indicator, and cycle characteristics can predict chronic disease later in life. We outline the ...
[171]
Study Updates | Apple Women's Health Study
October 2020: Tracking your period and treating the menstrual cycle as a vital sign could lead to earlier detection of many health and gynecologic conditions.
[172]
Associations Among Menstrual Cycle Length, Coronavirus... - LWW
Among unvaccinated participants reporting having COVID-19, we found a 1.45-day increase in menstrual cycle length as compared with their three preevent cycle- ...<|separator|>
[173]
COVID-19 vaccines and menstrual cycles | Study Updates
The Apple Women's Health Study explores the relationship between menstrual cycle length and COVID-19 vaccination.Missing: studies | Show results with:studies
[174]
Anti-COVID-19 Vaccination Alters the Menstrual Cycle and Dose ...
Jun 7, 2024 · Results: Anti-COVID-19 vaccination enhanced the probability to develop menstrual cycle alterations (OR 1.52, CI at 95% 1.2–1.8, p < 0.0001) and, ...
[175]
Menstrual Changes after COVID-19 Infection and COVID-19 ... - NIH
In recent studies, it is observed that SARS-CoV-2 infection itself, COVID-19 vaccines, and also stress in the pandemic may affect the menstrual cycle [2–4].
[176]
Big Data Begins to Crack the Case of Endometriosis - UCSF
Jul 31, 2025 · The research could improve diagnosis and, ultimately, treatments for endometriosis, preventing women from having to go on long diagnostic ...Missing: 2021-2025 | Show results with:2021-2025
[177]
Immunopathological insights into endometriosis: from research ...
Jul 18, 2025 · Translating the research achievements of ICPs and ICIs from cancer to endometriosis is a remarkable advance, and more evidence should be ...
[178]
Endometriosis: recent advances that could accelerate diagnosis and ...
In this article, we focus on recent developments in imaging technologies, on our improved understanding of mechanisms contributing to infertility, on drug ...Review · Endometriosis Aetiology... · Concluding Remarks
[179]
Sepranolone: A New Treatment for PMDD?
In this phase II study, sepranolone 10 mg administered subcutaneously during the late luteal phase reduced PMDD symptoms more than placebo.
[180]
Allopregnanolone Sparks Interest as New PMDD Treatment
In a new study at the MGH Center for Women's Mental Health, we are using a neurosteroid related to allopregnanolone to treat menopausal depression.
[181]
Emotion regulation-based internet-delivered cognitive behavioural ...
Jan 22, 2025 · The current study aims to evaluate the effects and cost-effectiveness of an internet-delivered CBT (ICBT) intervention for PMDD incorporating skills training ...
[182]
Menstrual cycle effects on cognitive performance: A meta-analysis
We conclude that the body of research in this meta-analysis does not support myths that women's cognitive abilities change across the menstrual cycle.
[183]
Effects of menstrual cycle phases on athletic performance and ...
The literature distinguishes up to seven MC phases with specific hormonal profiles: the early, mid, and late follicular phase, ovulation (OV), and early, mid, ...
[184]
COVID-19 pandemic and the menstrual cycle - Oxford Academic
For example: irregular and long menstrual cycles have been associated with a greater risk of premature mortality,10 and infrequent or absent menstruation can be ...<|separator|>
[185]
The impact of menstrual cycle phase and symptoms on sleep ...
The findings indicate that individual symptom frequency and menstrual complaints exert a stronger and more consistent impact on sleep and recovery stress ...
[186]
Why are women and people with cycles underrepresented in health ...
Women and people with cycles have historically been left out of medical research, with deadly consequences.
[187]
Why we know so little about women's health - AAMC
Mar 26, 2024 · Before 1993, women were rarely included in clinical trials. Today, the medical field still doesn't know how well many drugs and devices work for women.
[188]
Women's health research lacks funding – these charts show how
May 3, 2023 · Diseases that affect mainly women drop down. They are underfunded compared with the burden. Migraine, headaches, endometriosis and anxiety disorders, for ...
[189]
Shifting Priorities in Women's Health: 6 Trends to Watch in Clinical ...
Jun 17, 2025 · Women's health has historically been underrepresented in clinical research, often limited to reproductive endpoints and underfunded across ...
[190]
Challenges and future directions in menstrual cycle research - PMC
May 1, 2021 · The objective of this commentary is to describe methodological challenges for menstrual cycle research, whether those challenges differ for traditional ...
[191]
Menstrual cycle length variation by demographic characteristics from ...
May 29, 2023 · Menstrual cycles are on average 1.6 (95%CI: 1.2, 2.0) days longer for Asian and 0.7 (95%CI: 0.4, 1.0) days longer for Hispanic participants ...
[192]
Chronicling menstrual cycle patterns across the reproductive ...
May 3, 2024 · This paper aims to describe the dynamic differences in menstrual cycle characteristics and associated symptoms by age in a large global cohort of period- ...
[193]
OHSU study finds significant gaps in menstrual research and clinical ...
Feb 15, 2023 · The review study, published today in Obstetrics and Gynecology, aims to advance clinical understanding of current menstrual technologies.
[194]
Prevalence of menstrual problems and their association with ... - NIH
The most prevalent menstrual problems (dysmenorrhea and premenstrual symptoms) in the target population were strongly associated with stress.
[195]
Real-World Evidence Shows Gaps in Awareness, Medical Help ...
Sep 11, 2025 · The data suggest that women would rather accept discomfort than seek medical advice and that there may be a lack of sensitivity toward ...
[196]
The effect of air pollution exposure on menstrual cycle health using ...
Toxicological evidence suggests that ambient air pollution has endocrine-disrupting properties that can affect menstrual cycle functioning, which represents ...<|control11|><|separator|>
[197]
Global report reveals major gaps in menstrual health and hygiene in ...
May 28, 2024 · This drops to 1 in 5 schools in Least Developed Countries (17%), and only 1 in 10 schools (or 11%) in sub-Saharan Africa.
[198]
Global Health Priorities and the Neglect of Menstrual Health and ...
Dec 1, 2023 · In most parts of the world, menstruation is considered a taboo subject and managed in secrecy. Menstruators do not talk about their monthly ...
[199]
Oura Ring to be Used in New Study on Menstrual Research Across ...
Feb 27, 2025 · Oura Ring will be used to help better understand the physiology of the menstrual cycles of underrepresented groups in a new study led by Stanford University ...<|separator|>
[200]
Research priorities for improving menstrual health across the life ...
Research on menstrual health is required to understand menstrual needs and generate solutions to improve health, wellbeing, and productivity.
[201]
Overview of Research Gaps for Selected Conditions in Women's ...
Aug 20, 2024 · The discussions included the science of sex differences, research needs within reproductive and gynecologic health, and research efforts aimed ...